Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Disc Medicine Inc | IRON | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 27.00 | 04:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 27.00 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 25.60 - 77.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 27.00 | USD |
Disc Medicine Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 305.62M | 24.14M | - | 0 | -76.43M | -3.17 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Disc Medicine News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IRON Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 30.15 | 30.70 | 26.94 | 28.40 | 429,702 | -3.15 | -10.45% |
| 1 Month | 60.62 | 62.69 | 25.60 | 32.92 | 835,730 | -33.62 | -55.46% |
| 3 Months | 64.49 | 77.60 | 25.60 | 46.69 | 476,891 | -37.49 | -58.13% |
| 6 Months | 42.49 | 77.60 | 25.60 | 50.86 | 351,618 | -15.49 | -36.46% |
| 1 Year | 31.44 | 77.60 | 25.60 | 49.65 | 275,870 | -4.44 | -14.12% |
| 3 Years | 20.89 | 77.60 | 15.00 | 47.06 | 232,597 | 6.11 | 29.25% |
| 5 Years | 20.89 | 77.60 | 15.00 | 47.06 | 232,597 | 6.11 | 29.25% |
Disc Medicine Description
| Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of innovative therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The firm's pipeline includes investigational product candidates that affect heme biosynthesis and iron metabolism. |
